JPH0557275B2 - - Google Patents

Info

Publication number
JPH0557275B2
JPH0557275B2 JP869432A JP943286A JPH0557275B2 JP H0557275 B2 JPH0557275 B2 JP H0557275B2 JP 869432 A JP869432 A JP 869432A JP 943286 A JP943286 A JP 943286A JP H0557275 B2 JPH0557275 B2 JP H0557275B2
Authority
JP
Japan
Prior art keywords
group
formula
carbon atoms
hydrogen
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP869432A
Other languages
English (en)
Japanese (ja)
Other versions
JPS63183587A (ja
Inventor
Takehiko Yamane
Takushi Hashizume
Katsuji Yamashita
Kyoshi Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanegafuchi Chemical Industry Co Ltd
Original Assignee
Kanegafuchi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Industry Co Ltd filed Critical Kanegafuchi Chemical Industry Co Ltd
Priority to CN 86103776 priority Critical patent/CN1023320C/zh
Publication of JPS63183587A publication Critical patent/JPS63183587A/ja
Publication of JPH0557275B2 publication Critical patent/JPH0557275B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP61009432A 1985-02-05 1986-01-20 ベンゾキサジノリフアマイシン誘導体 Granted JPS63183587A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 86103776 CN1023320C (zh) 1986-01-20 1986-05-31 苯并嗪并利福霉素衍生物的制备方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60-20384 1985-02-05
JP2038485 1985-02-05

Publications (2)

Publication Number Publication Date
JPS63183587A JPS63183587A (ja) 1988-07-28
JPH0557275B2 true JPH0557275B2 (OSRAM) 1993-08-23

Family

ID=12025537

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61009432A Granted JPS63183587A (ja) 1985-02-05 1986-01-20 ベンゾキサジノリフアマイシン誘導体

Country Status (4)

Country Link
EP (1) EP0190709B1 (OSRAM)
JP (1) JPS63183587A (OSRAM)
CA (1) CA1256430A (OSRAM)
DE (1) DE3667286D1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0778022A1 (en) 1995-12-08 1997-06-11 Kaneka Corporation Treatment of chlamydia infectious diseases by rifamycin derivative

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2544375B2 (ja) * 1986-07-14 1996-10-16 鐘淵化学工業株式会社 アルキル置換ベンゾキサジノリフアマイシン誘導体
DE68924722T2 (de) * 1988-03-18 1996-04-18 Kanegafuchi Chemical Ind Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel.
CA1304363C (en) * 1988-11-01 1992-06-30 Takehiko Yamane 3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
JP2620399B2 (ja) * 1990-08-20 1997-06-11 鐘淵化学工業株式会社 ３′―アルキルまたはアリールシリルオキシベンゾキサジノリファマイシン誘導体
DE69632677T2 (de) * 1995-09-01 2005-06-16 Kaneka Corp. Verwendung eines Rifamycin-Derivates zur Herstellung eines Medikamentes zur Behandlung von Krankheiten verursacht durch Helicobacter pylori-Infektionen
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
DE69829905T2 (de) * 1997-02-28 2006-03-09 Kaneka Corp. Heilmittel für durch Helicobacter verursachte Krankheit
EP1001778B1 (en) * 1997-07-29 2003-07-09 Kaneka Corporation Use of a rifamycin derivative for treating mastitis in a domestic animal
US6486161B1 (en) 1998-07-29 2002-11-26 Kaneka Corporation Use of rifamycin derivative for treating mastitis in a domestic animal
CA2536378A1 (en) * 2003-08-22 2005-03-10 Activbiotics, Inc. Rifamycin analogs and uses thereof
US7265107B2 (en) 2004-03-10 2007-09-04 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
US7256187B2 (en) 2004-03-10 2007-08-14 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
CN108713020A (zh) 2016-03-04 2018-10-26 豪夫迈·罗氏有限公司 制备抗体-利福霉素缀合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130099C (OSRAM) * 1963-10-11

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0778022A1 (en) 1995-12-08 1997-06-11 Kaneka Corporation Treatment of chlamydia infectious diseases by rifamycin derivative

Also Published As

Publication number Publication date
JPS63183587A (ja) 1988-07-28
DE3667286D1 (de) 1990-01-11
EP0190709B1 (en) 1989-12-06
CA1256430A (en) 1989-06-27
EP0190709A1 (en) 1986-08-13

Similar Documents

Publication Publication Date Title
EP0366914B1 (en) 3'-Hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
JPH0557275B2 (OSRAM)
JPS62242663A (ja) １−デオキシノジリマイシンおよびそれのｎ−誘導体を製造する方法
Sternbach et al. Antispasmodics. I. Bicyclic basic alcohols
US4690919A (en) Benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
DE3787586T2 (de) Alkylsubstituiertes Benzoxazinorifamycinderivat, Verfahren zu seiner Herstellung und dieses enthaltendes antibakterielles Mittel.
Hochstein et al. Magnamycin B, a second antibiotic from Streptomyces halstedii
EP2871184B1 (en) Benzodioxole derivative and preparation method and use thereof
JPS5817454B2 (ja) アルキル化ヒドロキシルアミン及びその製法
CA1293503C (en) Substituted benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
US3459767A (en) Aminomethylindoles
EP0136831B1 (en) Azahomoerythromycin b derivatives and intermediates thereof
US3015657A (en) 1-carbalkoxy-4-(aminoalkanol) piperazines
CA2065526A1 (en) Aminophenol derivatives and pharmaceutical compositions thereof
FI73436B (fi) Foerfarande foer framstaellning av som laekemedel anvaendbara rifamyciner.
Grieco et al. Structure, absolute configuration, and synthesis of Stramonin-B, a new cytotoxic pseudoguaianolide
JPS5849383A (ja) ３，７―ジアザビシクロ〔３，３，１〕ノナン誘導体、その製法および抗不整脈剤組成物
KR20150042275A (ko) 3-포르밀리파마이신 sv 및 3-포르밀리파마이신 s의 3-(4-신나밀-l-피페라지닐) 아미노 유도체를 함유하는 제약 제제 및 그의 제조 방법
US3542927A (en) Reduction of blood sugar levels with aminomethylindoles
EP0055907B1 (en) Cis-c3",c4"-carbonate derivatives of oleandomycin-y, pharmaceutical compositions containing them, and intermediates therefor
JPS6330490A (ja) アミノベンゾキサジノリフアマイシン誘導体
US3178407A (en) 1-(piperidyl)-higher alkan-1-ols
JPS62240688A (ja) ヒドロキシメチル基を有するアミノベンゾキサジノおよびアミノベンゾチアジノリフアマイシン誘導体
JPS6335579A (ja) 含硫ベンゾキサジノリフアマイシン誘導体
JPH0517448A (ja) １４−Ｏ−ｐ−クロロベンゾイルアコニンおよび鎮痛・抗炎症剤

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term